SAN DIEGO -- A fixed-duration oral combination significantly reduced the risk of disease progression or death compared with ...

Combinations of chemotherapies and of chemoimmunotherapies (chemotherapy combined ... permit rational combinations of drugs aimed at optimizing treatment for CLL.

The AMPLIFY Phase III trial demonstrates that acalabrutinib plus venetoclax significantly improves progression-free survival ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

There is no evidence that watching and waiting negatively affects CLL outcomes. Chemotherapy and other drug therapies are cornerstones of CLL treatment. Your treatment may include multiple types ...

Current treatments for patients with relapsed or refractory chronic lymphocytic leukemia have shown better outcomes than ...

With a positive phase 3 trial in chronic lymphocytic leukemia (CLL), Eli Lilly hopes to convert Jaypirca’s unique accelerated ...

Grandad William Bennett, 69, was diagnosed with chronic lymphocytic leukaemia (CLL) 12 years ago, a type of blood cancer ...

If you receive a diagnosis at a more advanced stage of CLL with a higher risk, different treatments can improve your survival rate. Treatments usually include a combination of chemotherapy drugs ...

Treatment options can include chemotherapy, targeted drugs, immunotherapy, and bone marrow transplant. For more information about chronic lymphocytic leukemia, talk to your doctor. [MUSIC PLAYING] ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66th American ...